Abbott's MitraClip therapy receives National Reimbursement in Japan
Abbott announced the MHLW in Japan granted national reimbursement for the company's MitraClip therapy to treat people with mitral regurgitation, a serious, progressive heart disease in which the mitral valve does not close properly, allowing blood to flow backward into the heart. March 19, 2018